ScienceDex / Researcher record
John V. Heymach
- UT MD Anderson Cancer Center · Internal Medicine (NIH department code)
- UT MD Anderson Cancer Center (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
FY2024 NIH rank #4,741
- Program Leader
- R01 Holder
- Early Career
- Diverse Portfolio
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,143,901 | 5 | #4,741 |
| 2025 | $1,727,026 | 3 | #8,322 |
| 2026 | $679,129 | 1 | #26,604 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected5 records
- FY20253 records
- FY20261 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1894553Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Internal Medicine
FY2024 award records by amount
NIH award records listing John V. Heymach as a PI. Multi-PI records show the full award amount for context.
- 5U01CA256780-04U01Co-investigatorMolecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic responseUT MD Anderson Cancer Center · Internal Medicine (NIH department code)$575.2Kaward amount
- 5R01CA247975-05R01Contact PIMolecular features impacting drug resistance in atypical EGFR exon 18 and exon 20 mutant non-small cell lung cancers and the development of novel mutant-selective inhibitorsUT MD Anderson Cancer Center · Internal Medicine (NIH department code)$549.2Kaward amount
- 5R01CA234183-05R01Contact PITherapeutic strategies against EGFR exon 20 mutant lung cancerUT MD Anderson Cancer Center · Internal Medicine (NIH department code)$529.6Kaward amount
- $401.1Kaward amount
- 5P50CA070907-25P50Co-investigatorTargeting Lung Cancer Vulnerabilities$88.8Kaward amount
Award organizations
Organizations that administered FY2024 awards listing John V. Heymach as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUT MD Anderson Cancer Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4741
- 2024Entered Top 25% NationallyRanked #4741
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as John V. Heymach.
Anil K Sood
UT MD Anderson Cancer Center
2
shared awards
Christopher J. Logothetis
UT MD Anderson Cancer Center
2
shared awards
David S. Hong
UT MD Anderson Cancer Center
2
shared awards
Diane Bodurka
UT MD Anderson Cancer Center
2
shared awards
Dihua Yu
UT MD Anderson Cancer Center
2
shared awards
Eduardo Vilar Sanchez
UT MD Anderson Cancer Center
2
shared awards
Elizabeth J Shpall
UT MD Anderson Cancer Center
2
shared awards
Ernest T. Hawk
UT MD Anderson Cancer Center
2
shared awards
Fernando J Benavides
UT MD Anderson Cancer Center
2
shared awards
Funda Meric-Bernstam
UT MD Anderson Cancer Center
2
shared awards